Alecensa 150mg tablets | Apple pharmaceuticals


ALECENSA 150MG

Description :

Alecensa is a prescription drug which used under the guidance of doctor.
It is part used in the treatment of non-small cell lung cancer (NSCLC) expressing the ALK-EML4 (echinoderm microtubule-associated protein-like 4) fusion protein that causes proliferation of NSCLC cells.
Alecensa 150mg belongs to class of second generation oral drug which specificallyprevents the activity of anaplastic lymphoma kinase (ALK) tyrosine kinase.

Indication :

Alecensa 150mg is used for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC).

ADME

Peak plasma concentration 4 hours and bioavailability of Alecensa 37%
Alectinib bound to human plasma proteins 99%
Metabolized by CYP3A4 to its major active metabolite M4, the main circulating moieties in plasma, total radioactivity 76% constituting.
In oral administration, radioactivity 98% was excreted in feces. 84% dose was excreted in the feces unchanged Alectinib.
Half-life is 33 hours.

MECHANISM

Particularly, crizotinibprevents anaplastic lymphoma kinase (ALK), hepatocyte growth factor receptor (HGFR, Alectinib is a type of tyrosine kinase inhibitor which target ALK and RET. In nonclinical studies, Alectinib inhibits ALK phosphorylation and ALK-mediated activation of the downstream indicating proteins STAT3 and AKT anddecreases tumor cell viability in multiple cell lines harbouring ALK fusions, elaborations, or activating mutations.

PRECAUTION

Embryo-fetal toxicity:

depends on data from animal studies and its pharmacological action, Alecensa can cause fetal harm when administered to pregnant women.
While Alecensa administration, Symptomatic bradycardia may have observed; control heart rate and blood pressure regularly
Alecensa may causes Severe myalgia and elevated CPK resulted; advise patients to report any unexplained muscle pain, tenderness, or weakness;
Renal impairment occurred during Alecensa treatment; incidence of Grade ≥3 renal impairment was 1.7%, of which 0.5% were fatal events.

SIDE EFFECTS

Alecensa 150mg causes some side effects while administrating certain condition as follows :

COMMON SIDE EFFECTS

Muscle pain, Bradycardia, Tiredness, Constipation, Anemia , Hepatotoxicity, Feeling tired, Feeling less hungry than usual, Dark urine, Itchy skin, Nausea or vomiting, Abdominal Pain on the right side , Bleeding or bruising more easily than normal, Lung Problems, Trouble breathing, Shortness of breath , Cough, Fever .

MISSED DOSE

If the patient vomits after taking a dose of ALECENSA or missed to take a dose, then should not to take an extra dose, but to take the next dose at the regular time, skip the missed dose.

STORAGE

Store at below 30℃
Store the drug in original container

For More Information

Call us : +91-9987711567

Mail us :  applepharmaceutical@gmail.com

Comments

Post a Comment

Popular posts from this blog

velasof, velasof tablets ,uses - Myapplepharma

VELASOF TABLETS DESCRIPTION : Velasof   is the fixed dose combination of these two most widely used anti-viral agents. Sofosbuvir & Velpatasvir are directly acting anti-viral agents which are involved in the treatment of chronic hepatitis C viral infection. Sofosbuvir is usually combined with other anti-viral agent for exhibiting the prominent effects. DOSAGE BEFORE THE TREATMENT :  Care should be taken while using HCV medication in patients with HCV/HIV-1co infections, in this case HBV reactivation occurs.  Velasof   tablets are recommended for chronic condition of hepatitis C viral infection related to genotype 1, 2, 3, 4, 5 or 6. The dosing of  Velasof ; The usual recommended dose of  Velasof  is, one tablet should be administered orally as a single dose.  Velasof  tablet consist of 100mg of Velpatasvir & 400mg of Sofosbuvir.. WORKS AS :  This dynamic active moiety is get inserted into HCV RNA with the help of...
Read more

Today peoples are worried about NSLC – Xovoltib 30mg | Myapplepharma

  Xovoltib 30mg Description : Xovoltib 30mg is a prescription drugs which is used under the guidance of medical practioners. Xovoltib 30mg belongs to quinazoline and butanamide derivative which acts as a tyrosine kinase inhibitor of epidermal growth factor receptors (ERBB RECEPTORS) and is used in the treatment of metastatic NON-SMALL CELL LUNG CANCER. Indication : Xovoltib 30mg is indicated for treatment a certain type of lung cancer (non-small cell lung cancer) which has spread to other parts of the body. Mechanism : Xovoltib 30mg dose can blocking the activating sites called tyrosine kinases of various proteins within the cell.By stopping these targets, it will target the cancer will shrink.These proteins are most likely to develop cancer growth when the tumor includes the EGFR gene mutation. Precautions : Diarrhae: Most normal condition for people administrating this medications to have diarrhea. Certain situation this diarrhea can be serious. Severe diarrhea can c...
Read more

Sprycel 20mg tablet | Apple pharmaceuticals

Image
Sprycel 20mg Description : Sprycel 20mg belongs to oral dual BCR/ABL and Src group of tyrosine kinase inhibitor approved for use in patients with chronic myelogenous leukaemia (CML). The main aim of Sprycel , are BCRABL, SRC, Ephrin’s and GFR. Sprycel 20mg is a prescription drug which used under the supervision of doctor. Indication : Sprycel 20mg   is indicated for the treatment of adult patients having chronic myeloid leukaemia. Sprycel 20mg is indicated for the treatment of adult patients having acute lymphoblastic leukaemia. DRUG INTERACTION :  Sprycel 20mg combination with CYP3A4 inducers will reduces Dasatinib plasma concentration. Sprycel 20mg combination with antacids will decrease Dasatinib plasma concentration. Sprycel 20mg combination with H2 antagonists/proton pump inhibitors will decrease Dasatinib plasma concentration. PRECAUTION :  Using of Sprycel will results in Tumor lysis syndrome; maintain sufficient hydration and correct ur...
Read more